Literature DB >> 8660652

Purification and enzymatic characterization of recombinant prohormone convertase 2: stabilization of activity by 21 kDa 7B2.

N S Lamango1, X Zhu, I Lindberg.   

Abstract

Although previous efforts to produce significant quantities of purified prohormone convertase 2 from either recombinant or natural sources have been unsuccessful, our recent finding that the neuroendocrine polypeptide 7B2 is necessary for the biosynthesis of enzymatically active prohormone convertase 2 (PC2) has enabled us to obtain active recombinant enzyme from the conditioned medium of PC2-producing CHO cells supertransfected with cDNA coding for 21 kDa 7B2. The recombinant enzyme was purified to apparent homogeneity, with a 40% recovery, in milligram quantities. Two protein bands of Mrs 71 and 75 kDa were observed after SDS-PAGE followed by either Coomassie staining or Western blotting with PC2 antiserum. Spontaneous conversion of the 71- and 75-kDa species to the 66-kDa form occurred during incubation at pH 5.0; the degree of conversion correlated with a dramatic increase in activity. Kms of 124 and 131 microM and Kcats of 0.49 and 0.81 s(-1) were obtained for the substrates Cbz-Arg-Ser-Lys-Arg-AMC and Pyr-Arg-Thr-Lys-Arg-AMC, respectively. The pH optimum was 5.0, and the enzyme was inhibited by h7B2(155-185') p-CMS, and EDTA but not by other inhibitors tested. Interestingly, 21 kDa 7B2 was observed to copurify with the enzyme in a molar ratio of about 1:100 (7B2:PC2). Prior addition of recombinant 21 kDa 7B2 to activated 66 kDa PC2 provided significant protection against thermal denaturation. When coassociated 7B2 was mostly removed from activated PC2 through gel filtration, subsequent addition of recombinant 7B2 exerted a significant stabilizing effect on enzyme activity. Millimolar Ca2+ and pHs between 5 and 6 were required to observe this effect. Since these conditions resemble those thought to occur within secretory granules, and since 21 kDa 7B2 represents a stored secretory granule protein, our data suggest a physiological role for 21 kDa 7B2 in the stabilization of PC2 activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8660652     DOI: 10.1006/abbi.1996.0249

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  24 in total

1.  Identification and characterization of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processing.

Authors:  L D Fricker; A A McKinzie; J Sun; E Curran; Y Qian; L Yan; S D Patterson; P L Courchesne; B Richards; N Levin; N Mzhavia; L A Devi; J Douglass
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

Review 2.  Neuroendocrine secretory protein 7B2: structure, expression and functions.

Authors:  M Mbikay; N G Seidah; M Chrétien
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

3.  7B2 prevents unfolding and aggregation of prohormone convertase 2.

Authors:  Sang-Nam Lee; Iris Lindberg
Journal:  Endocrinology       Date:  2008-05-08       Impact factor: 4.736

4.  Neuropeptidomic analysis establishes a major role for prohormone convertase-2 in neuropeptide biosynthesis.

Authors:  Xin Zhang; Hui Pan; Bonnie Peng; Donald F Steiner; John E Pintar; Lloyd D Fricker
Journal:  J Neurochem       Date:  2009-12-07       Impact factor: 5.372

Review 5.  Prohormone and proneuropeptide processing. Recent progress and future challenges.

Authors:  M C Beinfeld
Journal:  Endocrine       Date:  1998-02       Impact factor: 3.633

6.  Processing of proaugurin is required to suppress proliferation of tumor cell lines.

Authors:  Akihiko Ozawa; Adam N Lick; Iris Lindberg
Journal:  Mol Endocrinol       Date:  2011-03-24

Review 7.  Deorphanization of novel peptides and their receptors.

Authors:  Akihiko Ozawa; Iris Lindberg; Bryan Roth; Wesley K Kroeze
Journal:  AAPS J       Date:  2010-05-06       Impact factor: 4.009

8.  Synthetic small-molecule prohormone convertase 2 inhibitors.

Authors:  Dorota Kowalska; Jin Liu; Jon R Appel; Akihiko Ozawa; Adel Nefzi; Robert B Mackin; Richard A Houghten; Iris Lindberg
Journal:  Mol Pharmacol       Date:  2008-12-12       Impact factor: 4.436

9.  Autoimmune hypophysitis of SJL mice: clinical insights from a new animal model.

Authors:  Shey-Cherng Tzou; Isabella Lupi; Melissa Landek; Angelika Gutenberg; Ywh-Min Tzou; Hiroaki Kimura; Giovanni Pinna; Noel R Rose; Patrizio Caturegli
Journal:  Endocrinology       Date:  2008-04-03       Impact factor: 4.736

10.  Posttranslational processing of FGF23 in osteocytes during the osteoblast to osteocyte transition.

Authors:  Hiroyuki Yamamoto; Bruno Ramos-Molina; Adam N Lick; Matthew Prideaux; Valeria Albornoz; Lynda Bonewald; Iris Lindberg
Journal:  Bone       Date:  2015-12-31       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.